Ahmed Mahmoud El Kerdawy

6PUBLICATIONS
15CO-AUTHORS
Cheminformatics and quantitative structure-activity relationshipsMolecular targetsBiomolecular modelling and design
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Nov 10, 2025
Novel chalcone 2-thiopyrimidine conjugates as dual VEGFR-2/BRAF inhibitors: design, synthesis, in vitro cytotoxicity, and molecular docking study.

Randa Atef Ibrahim Abdelaziz, Heba Abdelrasheed Allam, Ahmed Mahmoud El Kerdawy

|Aug 04, 2025
Quinolone as a Privileged Scaffold: A Brief Overview on Early Classical and Recent Advanced Synthetic Pathways, Innovative Neuroprotective Potential, and Structure-Activity Relationships.

Esraa Abdo Moustafa, Nahed Nasser Eid El-Sayed, Marwa A Fouad

|Dec 18, 2024
Furan- and Furopyrimidine-Based Derivatives: Synthesis, VEGFR-2 Inhibition, and In Vitro Cytotoxicity.

Akram H Abd El-Haleem, Manar Abd El-Karim Kassem, Mohamed R Elnagar

|May 24, 2022
Novel 2-(5-Aryl-4,5-Dihydropyrazol-1-yl)thiazol-4-One as EGFR Inhibitors: Synthesis, Biological Assessment and Molecular Docking Insights.

Tarfah Al-Warhi, Ahmed M El Kerdawy, Mohamed A Said

|May 01, 2020
Synthesis, Biological Evaluation and In Silico Studies of Certain Oxindole-Indole Conjugates as Anticancer CDK Inhibitors.

Tarfah Al-Warhi, Ahmed M El Kerdawy, Nada Aljaeed

|May 27, 2019
Receptor-based pharmacophore modeling, virtual screening, and molecular docking studies for the discovery of novel GSK-3β inhibitors.

Ahmed M El Kerdawy, Alaa A Osman, Marwa A Zaater

Pageof 1

Frequent Collaborators

2 joint publications

Wagdy M Eldehna

2 joint publications

Heba Abdelrasheed Allam

1 joint publications

Mohamed A Said

1 joint publications

Amgad Albohy